AbbVie sales blow past forecasts, fueled by Humira
October 31, 2014 at 08:08 AM EDT
Oct 31 (Reuters) - AbbVie, which earlier this month walked away from its $55 billion deal to buy Dublin drugmaker Shire, reported quarterly revenue well above Wall Street expectations, fueled by soaring sales of its Humira arthritis drug.